Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
US Market

Titan Pharmaceuticals (TTNP) Financial Statements

Compare
791 Followers

Titan Pharmaceuticals Financial Overview

Titan Pharmaceuticals's market cap is currently $3.59M. The company's EPS TTM is $-5.231; its P/E ratio is ―; Titan Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 184.00K$ 60.00K$ 1.53M$ 4.84M
Gross Profit$ 0.00$ 72.00K$ -136.00K$ 1.33M$ 4.37M
Operating Income$ -4.56M$ -7.28M$ -10.23M$ -9.35M$ -7.35M
EBITDA$ -4.56M$ -7.17M$ -10.04M$ -9.13M$ -7.06M
Net Income$ -4.71M$ -5.57M$ -10.18M$ -8.11M$ -20.73M
Balance Sheet
Cash & Short-Term Investments$ 2.83M$ 6.76M$ 2.94M$ 6.04M$ 5.41M
Total Assets$ 2.92M$ 8.09M$ 4.06M$ 7.99M$ 8.09M
Total Debt$ 0.00$ 565.00K$ 187.00K$ 299.00K$ 809.00K
Net Debt$ -2.83M$ -6.20M$ -2.75M$ -5.74M$ -4.60M
Total Liabilities$ 483.00K$ 1.44M$ 2.69M$ 2.86M$ 4.55M
Stockholders' Equity$ 2.44M$ 6.64M$ 1.36M$ 5.14M$ 3.53M
Cash Flow
Free Cash Flow$ -3.88M$ -7.09M$ -8.18M$ -7.92M$ -17.74M
Operating Cash Flow$ -3.88M$ -7.09M$ -8.18M$ -7.90M$ -17.20M
Investing Cash Flow$ 0.00$ 732.00K$ 0.00$ -23.00K$ -540.00K
Financing Cash Flow$ -62.00K$ 10.00M$ 4.98M$ 8.84M$ 17.93M
Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

Titan Pharmaceuticals Debt to Assets

Titan Pharmaceuticals Cash Flow

Titan Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis